State Of Maine Nerve Agent Antidote Kit Training Module - PowerPoint PPT Presentation

1 / 63
About This Presentation
Title:

State Of Maine Nerve Agent Antidote Kit Training Module

Description:

Miosis, rhinorrhea, SOB, wheezing, secretions, muscle weakness, GI effects ... Pronounced dyspnea, nausea, vomiting, diarrhea, weakness. Severe exposure ... – PowerPoint PPT presentation

Number of Views:226
Avg rating:3.0/5.0
Slides: 64
Provided by: cohs2
Category:

less

Transcript and Presenter's Notes

Title: State Of Maine Nerve Agent Antidote Kit Training Module


1
State Of MaineNerve Agent Antidote Kit Training
Module
  • Brian Langerman, CCEMT-P, I/C
  • EMS Coordinator City Of Saco
  • Kevin Bachi NREMT-P, BS
  • Kennebunk Fire Department

2
Nerve Agent Antidote Kit TrainingObjectives
  • Types of Incidents
  • Signs Symptoms of Nerve Agent Exposure
  • NAAKs
  • Protocols for NAAK Usage
  • Practice
  • Test

3
The Threat of Terrorism
4
Potential Probability vs. Impact
BIOLOGICAL AGENT
NUCLEAR WEAPON
IMPROVISED NUCLEAR DEVICE
POTENTIAL IMPACT
CHEMICAL AGENT OR TOXIC INDUSTRIAL CHEMICAL
RADIOACTIVE MATERIAL
PROBABILITY/LIKELIHOOD
5
Chemical Warfare AgentsHistorical Perspective
  • Chemicals used in military operations to kill,
    injure, or incapacitate
  • Battlefield use
  • World War I and Middle East conflicts
  • Terrorist use
  • Iraq, Matsumoto and Tokyo, Japan

6
Chemical Agent Terrorist Attacks
  • Matsumoto
  • Approximately 280 injured
  • 7 dead
  • Tokyo
  • 12 dead
  • Approximately 1,000 hospitalized
  • 5,500 sought medical care
  • 10 of first responders injured

7
Chemical Warfare Agents
  • Tabun, Sarin, Soman, VX
  • Mustard, Lewisite
  • Phosgene, Chlorine, Ammonia, Cyanide
  • Mace, Pepper Spray
  • Nerve Agents
  • Vesicants (Blister)
  • Industrial Chemicals
  • Riot Control Agents

8
Weapons of Mass Destruction
Commonly accepted methods for categorizing WMD
are CBRNE and BNICE
  • C (Chemical agents, including Toxic Industrial
    Chemicals (TIC) that may be used as WMD)
  • B (Biological hazards)
  • R (Radiological hazards)
  • N (Nuclear hazards)
  • E (Explosives)
  • B (Biological hazards)
  • N (Nuclear)
  • I (Incendiary)
  • C (Chemical Agents, including Toxic Industrial
    Chemicals)
  • E (Explosives)

9
Traits of a Terrorist
  • Terrorism IS
  • Politically motivated violence deliberately
    targeted at civilians
  • Instruments of social and political change
  • Terrorism seeks to break peoples will so they
    surrender principle to save themselves
  • Terrorism is NOT
  • Senseless or random
  • One persons terrorist is NOT anothers Freedom
    fighter
  • A viable negotiating technique
  • One to seek compromise

10
Factors of Threat
  • Surprise (relative to time of attack)
  • Means of attack
  • Target of the attack
  • Foreknowledge of the community response
  • Significant dates

11
Tactics
  • Mass casualties
  • Secondary devices
  • Multiple incidents
  • Rapid escalation of the hazards

12
Terrorist Weapon Choice
  • Depends on
  • Affordability of the weapon
  • Ability to move the weapon
  • Level of technology (usually low)
  • Ability to deny the results if intended objective
    was not achieved

13
How Nerve Agents Work
14
Normal Nerve Function
Nerve, gland or muscle
ACh
AchAcetylcholine stimulates muscle contraction,
gland secretion nerve to nerve conduction
15
Normal Nerve Function
ACh
Electrical Message continues
16
Normal Nerve Function
AChE
ACh
To stop further stimulation Ach is broken down by
AChE ,preventing overstimulation
17
Nerve Agents inhibit AChE
AChE
GB
ACh
Ach accumulates and causes over-stimulation of
nerves, muscles and glands
18
Nerve Agents
  • Tabun (GA), Sarin (GB), Soman (GD),VX
  • Nerve Agents are the most toxic of the chemical
    agents
  • Penetrate skin, eyes, lungs
  • Loss of consciousness, seizures, apnea, death
    after large amount
  • Diagnosis made clinically confirmed in
    laboratory (Nerve agents inhibit cholinesterase)

19
ROUTES OF EXPOSURE
  • Direct Contact
  • Inhalation
  • Ingestion

20
DIRECT CONTACT
  • Skin or eyes are touched with agent vapor or
    liquid
  • Nerve agents absorbed through skin
  • VX remains on skin and absorbed more completely
  • GB evaporates quickly, but still a threat
  • Scrapes, cuts or other skin damage offer direct
    entry points
  • freshly shaven skin, sunburn, insect bites,
    rashes
  • Eyes most sensitive organ for nerve agent vapor
    effects

21
INHALATION
  • Nerve agents enter through respiratory system
  • Rapidly and effectively enter into blood stream

Respiratory failure chief cause of death after
severe exposure
Nerve agent inhaled into respiratory system
22
INGESTION
  • Ingestion of contaminated food or drink,
    incidental hand to mouth or eye contact, smoking
  • Unlikely that agent will contaminate food or drink

Gastrointestinal system
23
Potential Exposure
  • No signs or symptoms
  • Reassure
  • Segregate in cold zone
  • Observe
  • Arrange transport to ED by bus or vans

24
Mild Exposure
  • Miosis, rhinorrhea - observation only
  • IV or IM atropine will not reverse miosis
  • Localized fasciculations and sweating
  • Exclusion (Hot) Zone No immediate treatment
  • Contamination Reduction (Warm) Zone
  • One MARK I Kit
  • Atropine 2 mg IM
  • 2-PAM 600 mg IM (Adult only)

25
Moderate Exposure
  • Miosis, rhinorrhea, SOB, wheezing, secretions,
    muscle weakness, GI effects
  • Exclusion (Hot) Zone No immediate treatment
  • Contamination Reduction (Warm) Zone
  • One to two MARK I kits (repeat every 5-10 min)
  • Atropine 2-4 mg IM (repeat every 5-10 min)
  • 2-PAM 600-1200 mg IM

26
Severe Exposure
  • Unconscious, seizing, flaccid, apnea
  • Exclusion (Hot) Zone
  • 3 MARK I kits IM as soon as possible
  • Contamination Reduction (Warm) Zone
  • 3 MARK I kits IM as soon as possible
  • Atropine 2-6 mg IM
  • 2PAM 600-1800 mg IM

27
Severe Exposure (cont.)
  • For seizures
  • Paramedics may administer
  • Midazolam (Versed) IM
  • Adult 5 mg IM

28
SLUDGEM / DUMBELS
  • Salivation
  • Lacrimation (Tears)
  • Urination
  • Defecation
  • GI Upset
  • Emesis (Vomiting)
  • Miosis (Pinpoint pupils)
  • Diarrhea
  • Urination
  • Miosis
  • Bronchospasm/bradycardia
  • Emesis
  • Lacrimation
  • Salivation

29
Effects of Nerve Agents
  • Organs with cholinergic receptors
  • Muscarinic (Atropine works)
  • Smooth muscles
  • Exocrine glands
  • Nicotinic (Atropine ineffective)
  • Skeletal muscles
  • Ganglia (Sympathetic/Parasympathetic)

30
Signs and Symptoms of Nerve AgentsMuscarinic
Sites
  • Increased secretions
  • Saliva
  • Tears
  • Runny nose
  • Secretions in airways
  • Secretions in gastrointestinal tract
  • Sweating

31
Signs and Symptoms of Nerve AgentsMuscarinic
Sites
  • Smooth muscle contraction
  • Eyes miosis
  • Airways bronchoconstriction (shortness of
    breath)
  • Gastrointestinal hyperactivity (nausea,
    vomiting, and diarrhea)

Dark room for 2 min 3,6,13,20,41, and 62days
after exposure
32
Signs and Symptoms of Nerve AgentsNicotinic
Sites (Over-stimulation of Ach)
  • Skeletal muscles
  • Fasciculations
  • Twitching
  • Weakness
  • Flaccid paralysis
  • Other (ganglionic)
  • Tachycardia
  • Hypertension

Miosis and fasciculations are the most reliable
evidence of OPP
33
Nerve AgentsOther Signs and Symptoms
  • Cardiovascular
  • Tachycardia, bradycardia
  • Heart block, ventricular arrhythmias
  • Most disappear once antidote is given
  • Central Nervous System
  • Acute
  • Loss of consciousness
  • Seizures
  • Apnea
  • Prolonged (4-6 weeks)
  • Psychological effects

34
Signs and Symptoms of Nerve Agents Vapor Exposure
  • Mild exposure
  • Miosis (dim vision, eye pain), rhinorrhea,
    dyspnea
  • Moderate exposure
  • Pronounced dyspnea, nausea, vomiting, diarrhea,
    weakness
  • Severe exposure
  • Immediate loss of consciousness, seizures, apnea,
    and flaccid paralysis
  • Vapor effects occur within seconds, peak within 5
    minutes if no effects within 20 minutes probably
    safe to assume there has not been an exposure.

35
Signs and Symptoms of Nerve Agents Liquid
Exposure
  • Mild exposure (to 18 hours)
  • Localized sweating
  • Fasciculations
  • No miosis
  • Moderate exposure (ltLD50) (to 18 hours)
  • Gastrointestinal effects
  • Miosis uncommon
  • Severe exposure (LD50) (lt30 minutes)
  • Sudden loss of consciousness
  • Seizures
  • Apnea
  • Flaccid paralysis
  • Death

10mg of VX
LD50lethal dose for 50 of the exposed
population while the other 50 would suffer
lesser effects
36
Diagnosis of Nerve Agent Exposure
  • Symptomatic
  • May be systemic or organ-specific
  • Combination of symptoms is more definitive
  • Situational
  • Multiple casualties with similar symptoms
  • Time or location factors in common

37
Treatment
  • Self-protection
  • Decontamination

38
Who Can Administer Mark 1 kits
  • In the State of Maine, an emergency responder can
    only administer the Mark 1 kits to themselves, or
    another emergency responder
  • If you and your partner have an exposure, and
    your partner becomes symptomatic, treat yourself
    first and then treat your partner

39
Nerve Agent Treatment
  • Escape the Area / Notify Dispatch
  • Decontaminate (strip down / H2O)
  • DO NOT ENTER ONCE SUSPICION EXISTS
  • IF Symptomatic use the NAAK Kits
  • Atropine
  • 2-PAMCl

40
Nerve AgentTreatment
  • Atropine
  • Side effects in normal people
  • Mydriasis (Pupil Dilation)
  • Blurred vision
  • Tachycardia
  • Decreased secretions and sweating

41
Nerve AgentTreatment
  • Pralidoxime Chloride (2PAM-Cl)
  • Remove nerve agent from AChE in absence of aging
    (ie enzyme and agent can become bound
    irreversibly- has to be given in 4-6 hrs (Sarin)
    60hrs (VX) and 2 min for Soman
  • 200 mg in each autoinjector
  • No effects at muscarinic sites
  • Helps at nicotinic sites

This antidote breaks the bond between the nerve
Agent and AChE and removes the agent
42
MARK I Injections - Dispersal
43
Nerve Agent Treatment
  • Treatment regimen
  • No signs/symptoms
  • Reassure
  • Observe
  • Vapor 1 hour
  • Liquid Up to 18 hours

44
Nerve Agent Treatment
  • One MARK I kit (2 mg atropine/ 600 mg 2 -PAMCl)
  • Parenteral atropine will not reverse miosis
  • Mild vapor exposure
  • Miosis, rhinorrhea - observation only
  • Increasing SOB treat
  • Mild liquid exposure
  • Localized fasiculations sweating - treat

45
Nerve AgentTreatment
  • Moderate vapor or liquid exposure
  • One or two MARK I kits

46
Nerve AgentTreatment
  • Severe - vapor or liquid
  • Give 3 MARK I kits
  • Airway
  • Ventilation/O2
  • Consider Midazolam 5 mg IM and repeat the
    atropine every 5 to10 minutes as needed
  • Repeat 2-PAMCl

47
Treatment
  • Airway/ventilation
  • Antidotes
  • Atropine
  • Pralidoxime
  • (2-PAM)
  • Midazolam

48
Atropine
  • Given IV, IM, ET
  • Antagonizes muscarinic effects
  • Dries secretions relaxes smooth muscles
  • Does not affect miosis, fasciculations, muscle
    strength (nicotinic)
  • May cause cardiac arrhythmias IV in hypoxic
    patient (v-fib)

49
Atropine
  • Starting dose - 2 mg
  • Maximum cumulative dose - 20 mg
  • Side effects in normal people
  • Dilated pupils
  • Blurred vision
  • Tachycardia
  • Decreased sweating

50
Atropine
  • Atropine - How much to give?
  • Until secretions are drying or dry
  • Until ventilation is easy
  • If conscious, and victim is comfortable
  • Dont rely on heart rate/pupil size

51
Atropine Overdose
  • If excessive atropine is administered
  • Signs of atropinization will become even more
    severe and patient may also develop
  • blurring of vision
  • delirium
  • urinary retention
  • When signs and symptoms of atropinization
    develop, no more atropine should be injected
    until atropinization subsides

52
Pralidoxime Chloride (2-PAM)
  • Remove nerve agent from AChE in absence of aging
    (2-PAM crowbar)
  • Does not reverse muscarinic effects on glands and
    smooth muscles
  • Helps at nicotinic sites

53
2-PAM Adverse Reactions
  • 2-PAM may cause
  • blurred vision
  • diplopia
  • impaired accommodation
  • headache
  • nausea
  • dizziness
  • drowsiness
  • tachycardia
  • hyperventilation
  • hypertension

These are relatively mild when compared to
effects of nerve agents
54
Midazolam
  • Decreases seizure activity
  • Reduces seizure-induced brain injury
  • Must observe carefully for respiratory depression

55
Autoinjectors
56
Auto-Injectors
  • Simple, compact injection systems
  • Permit rapid injection of required antidotes
  • Prevent needle from being subject to
    cross-contamination
  • Enable rapid and accurate administration even if
    care giver or patient is in protective clothing

57
Directions for Use
  • 1. Remove safety cap
  • Yellow on atropine
  • Gray on 2-PAM
  • Mark I kit clip holds the safety caps
  • May not notice if using Mark I kits
  • Do not touch colored end of injector after
    removing cap - injector will inject
  • into fingers or hand

58
Directions for Use
  • 2. Hold injector - either like a pen or in fist.
  • 3. Place colored end (Green on atropine, black
    on 2-PAM) on thickest part of thigh and press
    hard until injector functions.
  • Pressure automatically activates the spring,
    inserts the needle into the muscle and injects
    the medication

59
Directions for Use
  • 4. After auto-injector has been activated, empty
    container should be disposed of properly
  • It cannot be refilled nor can the protruding
  • needle be retracted
  • It should be disposed of in a sharps
    container
  • 5. Note dosage on triage tag or write on chest
    or forehead of patient

60
Riot Control Agents Summary
  • Irritating agents, lacrimators, tear gas
  • Cause reaction in
  • Eyes burning, tearing, eyelid spasm, redness
  • Airways burning, coughing, dyspnea
  • Skin burning, erythema
  • Eye irrigation and supportive care

61
Nerve Agent Summary
  • Vapor exposure
  • Symptoms develop suddenly
  • Most ambulatory victims require minimal
    intervention
  • Risk of secondary contamination, which is
    minimized by removing the victims clothing
  • Requires immediate access to antidotes
  • Liquid exposure
  • Symptoms delayed minutes to hours
  • Greater need for decontamination
  • High risk of secondary contamination victims
    require decontamination (clothing removal
    washdown)
  • Requires immediate access to antidotes

62
Chemical Agent Summary
  • Vapor exposure
  • Nerve agent symptoms develop suddenly, mustard
    and phosgene symptoms are delayed
  • Most ambulatory victims require minimal
    intervention
  • Risk of secondary contamination
  • Requires airway management antidotes for nerve
    agents and Lewisite

63
Chemical Agent Summary
  • Liquid exposure
  • Symptoms delayed minutes to hours
  • Greater need for decontamination
  • Risk of secondary contamination, victims require
    clothing removal decontamination
  • Requires immediate access to antidotes

64
ANY QUESTIONS ???
Write a Comment
User Comments (0)
About PowerShow.com